PTPRC and neoplasm: B16-OVA tumor-bearing mice treated with checkpoint inhibitors and SLA–OVA had the highest numbers of CD45+ cells (Figure 3G) and CD8+ cells and these cells were found close to dying or dead tumor cells (Figure 3H) and were widely dispersed throughout the viable tumor tissue (Figure 3I).